Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Tharimmune, Inc.

Equities

THAR

US4327052001

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.3905 USD +3.86% Intraday chart for Tharimmune, Inc. +7.10% -23.28%
May. 09 Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 23 Tharimmune, Inc. Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dawson James Downgrades Hillstream BioPharma to Neutral From Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THAR Stock
  4. News Tharimmune, Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW